Johnson et al., 1999, vol. 274, 7, pp. 4053-4058.* |
Fuller et al., “Intracellular Production of βA4 Amyloid of Alzheimer's Disease: Modulation by Phosphoramidon and Lack of Coupling to the Secretion of the Amyloid Precursor Protein,” Biochem., 1995, 34(25):8091-8098. |
Naidu et al., “β-Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells,” J. Biol. Chem., 1995, 270(3):1369-1374. |
Qiu et al., “Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation,” J. Biol. Chem., 1998, 273(49):32730-32738. |
Saido, “Alzheimer's Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid,” Neurobiol. Of Aging, 1998, 19(IS):S69-S75. |
Takaki et al., “Biochemical Identification of the Neutral Endopeptidase Family Member Responsible for the Catabolism of Amyloid β Peptide in the Brain,” J. Biochem., 2000, 128:897-902. |
Tummolo et al., “Quantification of Alzheimer's β-amyloid peptide levels in the plasma, CSF and brain tissue from guinea pig following administration of classical proteases inhibitors,” Soc. Neurosci., 1996, 22(2):1170, Abstract #461.10. |
Brown et al., “Functional Significance of the Isoforms of Endothelin-Converting Enzyme-1,” J. Cardiovasc. Pharmacol., 2000, 36(Suppl. 1):S26-S27. |
Eckman et al., “Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme,” J. Biol. Chem., 2001, 276(27):24540-24548. |